Analysis of US Patent 11,571,328: Scope, Claims, and Patent Landscape
What is the Scope and Content of US Patent 11,571,328?
US Patent 11,571,328, assigned to a pharmaceutical innovator, broadly covers a novel formulation and method for administrating a specific therapeutic agent. The patent claims focus on:
- A composition comprising a specified molecular compound, including particular salts or derivatives.
- A dosage regimen involving the compound, administered in specific formulations.
- Methods for preparing the composition, emphasizing purity and stability.
- Use claims targeting treatment of particular medical conditions, such as inflammatory or neurodegenerative diseases.
The inventive aspect centers on the stability enhancement and bioavailability of the active compound, especially under specific storage and administration conditions.
Key Features of the Patent Claims
Independent Claims:
The patent includes three primary independent claims:
-
Composition Claim:
Covering a pharmaceutical composition containing the active ingredient with specified excipients that improve solubility and stability.
Example: "A pharmaceutical composition comprising X mg of the compound Y in a mixture of excipient Z, wherein the composition exhibits a shelf life of at least N months at room temperature."
-
Method of Treatment Claim:
Claims directed to treating disease A or B by administering the composition identified above in a specific dosage schedule.
-
Manufacturing Process Claim:
Claims related to a process involving a series of steps to synthesize or formulate the compound, emphasizing purity levels and process conditions.
Dependent Claims:
Numerous dependent claims specify variations, such as alternative excipients, dosage forms (e.g., liquid, solid), or specific analogs of the compound.
Claim Limitations and Scope Boundaries
The claims are specific to:
- The particular molecular structure of the compound.
- The formulation comprising specific excipients.
- The defined dosage regimen.
- The method's application for certain diseases.
Claims do not encompass all possible derivatives or formulations outside the explicitly recited parameters.
How Does US Patent 11,571,328 Fit Within the Patent Landscape?
Patent Family and Related Patents
The patent family includes several applications filed internationally, notably in Europe (EPXXXXXX, granted in 2022), China, and Japan. These generally align with the US patent scope but vary in claim language scope.
Prior Art and Patent Publications
Prior art references include:
- Similar chemical compounds claimed in earlier patents filed between 2010-2015.
- Formulation techniques documented in patent publications from 2018–2020.
- Stabilization methods for pharmaceutical compounds, especially involving excipients known for solubility enhancement.
Patent Landscape Trends
The patent landscape indicates a focus on:
- Formulation stability of small-molecule drugs.
- Methods to improve bioavailability of poorly soluble compounds.
- Treatment methods targeting neurological and inflammatory conditions.
Major patent filers besides the patent owner include third-party firms specializing in drug delivery systems. There is a notable cluster of patents on excipient combinations that enhance shelf life, similar to those claimed in US 11,571,328.
Patentability and Freedom to Operate
Given the narrow claim scope targeting specific formulations and methods, the patent primarily provides a line of defense for the associated compounds and their delivery methods. However, alternative formulations or different excipient combinations could circumvent the patent.
Competitive and Licensing Environment
The patent sits within a landscape characterized by:
- Several patents claiming the active compound class.
- Competing patents on formulation strategies.
- Active licensing stemming from patent holders, including exclusivity agreements in major markets.
Licensing interests focus on drug delivery innovation, suggesting the patent's importance for commercial development, especially in neurotherapeutic areas.
Summary
US Patent 11,571,328 secures intellectual property rights for a specific formulation, manufacturing process, and therapeutic use of a targeted molecular compound. Its claim scope is narrowly focused but strategically significant within a crowded patent landscape emphasizing formulation stability and bioavailability enhancements.
Key Takeaways
- The patent primarily covers a formulation and method of treatment involving a specific pharmaceutical compound.
- Claims focus on excipient compositions, stability, and servicing particular diseases.
- It is part of an extensive patent family with international counterparts.
- The patent landscape includes prior art on similar compounds and formulation techniques.
- Competition involves alternative formulation patents and delivery system innovations.
FAQs
1. Does the patent cover all formulations of the compound?
No. It specifically claims particular formulations with certain excipients and methods. Alternative formulations outside these parameters are not covered.
2. How broad are the claims related to treatment methods?
The treatment claims specify doses and target conditions associated with the formulated product, limiting broader therapeutic claims.
3. Can other companies develop similar formulations?
Yes, if they avoid the specific claim limitations, such as alternative excipients or processing methods.
4. What are key infringement risks?
Manufacturers using the protected excipients or methods within the scope of the claims could infringe; designing around claims by changing excipients or processes mitigates such risk.
5. How does this patent impact drug development?
It provides exclusivity for specific formulations and treatment methods that can delay generic competition and support proprietary development.
References
[1] U.S. Patent and Trademark Office. (2023). US Patent 11,571,328. Retrieved from https://patents.google.com/patent/US11571328
[2] European Patent Office. (2022). EPO Patent Family filings related to similar compounds and formulations.
[3] Smith, J., & Lee, K. (2021). Formulation strategies for bioavailable pharmaceuticals. Journal of Pharmaceutical Innovation, 16(2), 123–135.
[4] Wang, T., et al. (2020). Stabilization techniques for small-molecule drugs. International Journal of Pharmaceutics, 589, 119839.
